| Epidermal growth factor-related peptides and their receptors in human malignancies DS Salomon, R Brandt, F Ciardiello, N Normanno Critical reviews in oncology/hematology 19 (3), 183-232, 1995 | 3253 | 1995 |
| EGFR antagonists in cancer treatment F Ciardiello, G Tortora New England Journal of Medicine 358 (11), 1160-1174, 2008 | 2017 | 2008 |
| Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective … W De Roock, B Claes, D Bernasconi, J De Schutter, B Biesmans, ... The lancet oncology 11 (8), 753-762, 2010 | 1929 | 2010 |
| Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS … E Van Cutsem, CH Kohne, I Láng, G Folprecht, MP Nowacki, S Cascinu, ... J clin Oncol 29 (15), 2011-2019, 2011 | 1702 | 2011 |
| Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial A Rittmeyer, F Barlesi, D Waterkamp, K Park, F Ciardiello, J Von Pawel, ... The Lancet 389 (10066), 255-265, 2017 | 1564 | 2017 |
| A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor F Ciardiello, G Tortora Clinical Cancer Research 7 (10), 2958-2970, 2001 | 1265 | 2001 |
| Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor F Ciardiello, R Caputo, R Bianco, V Damiano, G Pomatico, S De Placido, ... Clinical Cancer Research 6 (5), 2053-2063, 2000 | 1190 | 2000 |
| ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making HJ Schmoll, E Van Cutsem, A Stein, V Valentini, B Glimelius, ... Annals of oncology 23 (10), 2479-2516, 2012 | 1129 | 2012 |
| ESMO consensus guidelines for the management of patients with metastatic colorectal cancer E Van Cutsem, A Cervantes, R Adam, A Sobrero, JH Van Krieken, ... Annals of Oncology 27 (8), 1386-1422, 2016 | 1022 | 2016 |
| Chronic inflammation and oxidative stress in human carcinogenesis A Federico, F Morgillo, C Tuccillo, F Ciardiello, C Loguercio International Journal of Cancer 121 (11), 2381-2386, 2007 | 800 | 2007 |
| Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor F Ciardiello, R Caputo, R Bianco, V Damiano, G Fontanini, S Cuccato, ... Clinical cancer research 7 (5), 1459-1465, 2001 | 755 | 2001 |
| ZD6474, an orally available inhibitor of KDR tyrosine kinase activity, efficiently blocks oncogenic RET kinases F Carlomagno, D Vitagliano, T Guida, F Ciardiello, G Tortora, G Vecchio, ... Cancer research 62 (24), 7284-7290, 2002 | 624 | 2002 |
| Expression of epidermal growth factor receptor correlates with disease relapse and progression to androgen-independence in human prostate cancer G Di Lorenzo, G Tortora, FP D’Armiento, G De Rosa, S Staibano, ... Clinical Cancer Research 8 (11), 3438-3444, 2002 | 509 | 2002 |
| Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: pooled analysis of the CRYSTAL and OPUS randomised clinical trials C Bokemeyer, E Van Cutsem, P Rougier, F Ciardiello, S Heeger, ... European journal of cancer 48 (10), 1466-1475, 2012 | 507 | 2012 |
| Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense … F Ciardiello, R Bianco, V Damiano, G Fontanini, R Caputo, G Pomatico, ... Clinical Cancer Research 6 (9), 3739-3747, 2000 | 492 | 2000 |
| Fluorouracil, leucovorin, and irinotecan plus cetuximab treatment and RAS mutations in colorectal cancer EV Cutsem, HJ Lenz, CH Kohne, V Heinemann, S Tejpar, I Melezínek, ... | 479 | 2015 |
| KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer W De Roock, V De Vriendt, N Normanno, F Ciardiello, S Tejpar The lancet oncology 12 (6), 594-603, 2011 | 476 | 2011 |
| Antitumor effects of ZD6474, a small molecule vascular endothelial growth factor receptor tyrosine kinase inhibitor, with additional activity against epidermal growth factor … F Ciardiello, R Caputo, V Damiano, R Caputo, T Troiani, D Vitagliano, ... Clinical Cancer Research 9 (4), 1546-1556, 2003 | 419 | 2003 |
| Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225 F Ciardiello, R Bianco, V Damiano, S De Lorenzo, S Pepe, S De Placido, ... Clinical Cancer Research 5 (4), 909-916, 1999 | 403 | 1999 |
| Pathogenesis, prevention, diagnosis and treatment of breast cancer R Shah, K Rosso, SD Nathanson World journal of clinical oncology 5 (3), 283, 2014 | 399* | 2014 |
